Painter, Mark M. http://orcid.org/0000-0002-0180-2748
Johnston, Timothy S.
Lundgreen, Kendall A.
Santos, Jefferson J. S. http://orcid.org/0000-0001-5895-4163
Qin, Juliana S. http://orcid.org/0000-0002-6352-9601
Goel, Rishi R.
Apostolidis, Sokratis A. http://orcid.org/0000-0002-0224-0097
Mathew, Divij
Fulmer, Bria
Williams, Justine C.
McKeague, Michelle L.
Pattekar, Ajinkya
Goode, Ahmad
Nasta, Sean
Baxter, Amy E. http://orcid.org/0000-0002-1555-0713
Giles, Josephine R.
Skelly, Ashwin N. http://orcid.org/0000-0002-1565-3376
Felley, Laura E.
McLaughlin, Maura
Weaver, Joellen
Ritchie, Marylyn D.
Feldman, Michael D.
Weaver, JoEllen
Naseer, Nawar
Poindexter, Afiya
Brock, Ashlei
Hu-Sain, Khadijah
Ko, Yi-An
Livingstone, Meghan
Vadivieso, Fred
Kloter, Ashley
DerOhannessian, Stephanie
Tran, Teo
Morrel, Linda
Haubein, Ned
Dunn, Joseph
Verma, Anurag
Morse, Colleen
Risman, Marjorie
Judy, Renae
Verma, Shefali S.
Bradford, Yuki
Dudek, Scott
Drivas, Theodore
Kuthuru, Oliva
Dougherty, Jeanette
Adamski, Sharon
Long, Sherea
Kee, Macy
Clendenin, Cynthia http://orcid.org/0000-0003-4535-2088
da Silva Antunes, Ricardo http://orcid.org/0000-0001-9785-5272
Grifoni, Alba http://orcid.org/0000-0002-2209-5966
Weiskopf, Daniela
Sette, Alessandro http://orcid.org/0000-0001-7013-2250
Huang, Alexander C. http://orcid.org/0000-0002-0099-0492
Rader, Daniel J.
Hensley, Scott E. http://orcid.org/0000-0002-2928-7506
Bates, Paul
Greenplate, Allison R. http://orcid.org/0000-0002-2614-3072
Wherry, E. John http://orcid.org/0000-0003-0477-1956
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI082630, AI108545, AI155577, AI149680, U19AI082630, 75N9301900065, 75N9301900065, AI152236)
Parker Foundation
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001878)
Article History
Received: 5 February 2023
Accepted: 7 August 2023
First Online: 21 September 2023
Competing interests
: E.J.W. is a member of the Parker Institute for Cancer Immunotherapy which supported this study. S.E.H. has received consultancy fees from Sanofi Pasteur, Lumen, Novavax and Merk for work unrelated to this report. E.J.W. is an advisor for Danger Bio, Janssen, New Limit, Marengo, Pluto Immunotherapeutics Related Sciences, Santa Ana Bio, Synthekine and Surface Oncology. E.J.W. is a founder of and holds stock in Surface Oncology, Danger Bio and Arsenal Biosciences. A.S. is a consultant for Gritstone Bio, Flow Pharma, Moderna, AstraZeneca, Qiagen, Fortress, Gilead, Sanofi, Merck, RiverVest, MedaCorp, Turnstone, NA Vaccine Institute, Emervax, Gerson Lehrman Group and Guggenheim. La Jolla Institute for Immunology has filed for patent protection for various aspects of T cell epitope and vaccine design work. The remaining authors declare no competing interests.